Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2022.04.30
2022年一季度报告
2022.04.12
海普瑞：2021年年度报告(更新后）
2021.10.28
2021年第三季度报告
2021.08.27
2021年半年度报告
2021.08.27
2021年半年度报告摘要
2021.04.29
2021年第一季度报告全文
2021.04.29
2021年第一季度报告正文
2021.03.30
2020年年度报告摘要
2021.03.30
2020年年度报告
2020.10.30
2020年第三季度报告全文
第一页
上一页
1
2
3
4
5
下一页
最后一页
